[CRVS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 9.74%
YoY- 17.45%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,978 -11,643 -10,509 -10,498 -11,631 -14,301 -11,929 5.79%
Tax 0 0 -180 0 0 0 -219 -
NP -12,978 -11,643 -10,509 -10,498 -11,631 -14,301 -11,929 5.79%
Tax Rate - - - - - - - -
Total Cost 12,978 11,643 10,509 10,498 11,631 14,301 11,929 5.79%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.44 -0.40 -0.36 -0.36 -0.40 -0.63 -0.58 -16.86%
EPS Diluted -0.44 -0.40 -0.36 -0.36 -0.40 -0.63 -0.58 -16.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.